KRAS and cancer: The reason that this association was observed only in KRAS wild-type patients was probably that the regulation of this signal pathway depends mainly on the binding of ligands such as AREG and EREG to HER receptors in KRAS wild-type individuals, which suggests that higher expression of ligands results in up-regulation of this pathway and leads to cancer cell proliferation and the likelihood of metastasis.